288 related articles for article (PubMed ID: 23454125)
1. CHFR is negatively regulated by SUMOylation-mediated ubiquitylation.
Bae SJ; Kwon YE; Kim M; Seol JH
Biochem Biophys Res Commun; 2013 Apr; 433(2):194-9. PubMed ID: 23454125
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation negatively regulates the stability of CHFR tumor suppressor.
Kwon YE; Bae SJ; Kim M; Seol JH
Biochem Biophys Res Commun; 2013 Jan; 430(1):213-7. PubMed ID: 23131550
[TBL] [Abstract][Full Text] [Related]
3. CHFR negatively regulates SIRT1 activity upon oxidative stress.
Kim M; Kwon YE; Song JO; Bae SJ; Seol JH
Sci Rep; 2016 Nov; 6():37578. PubMed ID: 27883020
[TBL] [Abstract][Full Text] [Related]
4. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity.
Oh YM; Yoo SJ; Seol JH
Biochem Biophys Res Commun; 2007 Jun; 357(3):615-9. PubMed ID: 17442268
[TBL] [Abstract][Full Text] [Related]
6. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
Kang D; Chen J; Wong J; Fang G
J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
[TBL] [Abstract][Full Text] [Related]
7. Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells.
Cal R; García-Arguinzonis M; Revuelta-López E; Castellano J; Padró T; Badimon L; Llorente-Cortés V
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):369-77. PubMed ID: 23241409
[TBL] [Abstract][Full Text] [Related]
8. Identification of phosphorylation sites of TOPORS and a role for serine 98 in the regulation of ubiquitin but not SUMO E3 ligase activity.
Park HJ; Zheng H; Kulkarni D; Kerrigan J; Pungaliya P; Saleem A; Rubin EH
Biochemistry; 2008 Dec; 47(52):13887-96. PubMed ID: 19053840
[TBL] [Abstract][Full Text] [Related]
9. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
10. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
[TBL] [Abstract][Full Text] [Related]
12. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of Chfr is crucial for its checkpoint function.
Kwon YE; Kim YS; Oh YM; Seol JH
Mol Cells; 2009 Mar; 27(3):359-63. PubMed ID: 19326084
[TBL] [Abstract][Full Text] [Related]
14. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
[TBL] [Abstract][Full Text] [Related]
16. CHFR functions as a ubiquitin ligase for HLTF to regulate its stability and functions.
Kim JM; Cho EN; Kwon YE; Bae SJ; Kim M; Seol JH
Biochem Biophys Res Commun; 2010 May; 395(4):515-20. PubMed ID: 20388495
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PTEN ubiquitylation and SUMOylation using molecular traps.
Lang V; Aillet F; Da Silva-Ferrada E; Xolalpa W; Zabaleta L; Rivas C; Rodriguez MS
Methods; 2015 May; 77-78():112-8. PubMed ID: 25224693
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction between Chfr and Kif22 controls genomic stability.
Maddika S; Sy SM; Chen J
J Biol Chem; 2009 May; 284(19):12998-3003. PubMed ID: 19321445
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
[TBL] [Abstract][Full Text] [Related]
20. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity.
Chaturvedi P; Sudakin V; Bobiak ML; Fisher PW; Mattern MR; Jablonski SA; Hurle MR; Zhu Y; Yen TJ; Zhou BB
Cancer Res; 2002 Mar; 62(6):1797-801. PubMed ID: 11912157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
